Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0WZX4
|
|||
| Drug Name |
AB-205
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Non-hodgkin lymphoma [ICD-11: 2B33.5; ICD-10: C82-C85; ICD-9: 200, 202] | Phase 1/2 | [1] | |
| Company |
Angiocrine Bioscience
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03925935) Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.